Invesco Dorsey Wright Healthcare Momentum ETF (PTH)
NASDAQ: PTH · Real-Time Price · USD
54.15
-0.17 (-0.32%)
Nov 28, 2025, 4:00 PM EST - Market closed
PTH Holdings Information
PTH is an equity ETF with a total of 58 individual holdings. The top holdings are Cidara Therapeutics stock at 6.26%, Insmed at 4.91%, Medpace Holdings at 4.65%, Guardant Health at 4.45%, and Nektar Therapeutics at 3.74%.
Total Holdings
25
Top 10 Percentage
40.79%
Asset Class
Equity
ETF Category
Health
Assets
127.43M
PE Ratio
26.92
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CDTX | Cidara Therapeutics, Inc. | 6.26% |
| 2 | INSM | Insmed Incorporated | 4.91% |
| 3 | MEDP | Medpace Holdings, Inc. | 4.65% |
| 4 | GH | Guardant Health, Inc. | 4.45% |
| 5 | NKTR | Nektar Therapeutics | 3.74% |
| 6 | NTRA | Natera, Inc. | 3.73% |
| 7 | CELC | Celcuity Inc. | 3.54% |
| 8 | THC | Tenet Healthcare Corporation | 3.40% |
| 9 | BSX | Boston Scientific Corporation | 3.15% |
| 10 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.96% |
| 11 | HIMS | Hims & Hers Health, Inc. | 2.51% |
| 12 | TVTX | Travere Therapeutics, Inc. | 2.48% |
| 13 | BBIO | BridgeBio Pharma, Inc. | 2.42% |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | 2.32% |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.31% |
| 16 | PTGX | Protagonist Therapeutics, Inc. | 2.16% |
| 17 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.08% |
| 18 | MLYS | Mineralys Therapeutics, Inc. | 2.02% |
| 19 | ATEC | Alphatec Holdings, Inc. | 1.97% |
| 20 | RDNT | RadNet, Inc. | 1.82% |
| 21 | BTSG | BrightSpring Health Services, Inc. | 1.80% |
| 22 | ARQT | Arcutis Biotherapeutics, Inc. | 1.78% |
| 23 | PTCT | PTC Therapeutics, Inc. | 1.69% |
| 24 | ALHC | Alignment Healthcare, Inc. | 1.65% |
| 25 | DOCS | Doximity, Inc. | 1.64% |
As of Nov 26, 2025